
via Johns Hopkins University
Perhaps no region of the brain is more fittingly named than the claustrum, taken from the Latin word for “hidden or shut away.” The claustrum is an extremely thin sheet of neurons deep within the cortex, yet it reaches out to every other region of the brain. Its true purpose remains “hidden away” as well, with researchers speculating about many functions. For example, Francis Crick of DNA-discovery fame believed that the claustrum is the seat of consciousness, responsible for awareness and sense of self.
What is known is that this region contains a large number of receptors targeted by psychedelic drugs such as LSD or psilocybin ¾ the hallucinogenic chemical found in certain mushrooms. To see what happens in the claustrum when people are on psychedelics, Johns Hopkins Medicine researchers compared the brain scans of people after they took psilocybin with their scans after taking a placebo.
Their findings were published online on May 23, 2020, in the journal NeuroImage.
The scans after psilocybin use showed that the claustrum was less active, meaning the area of the brain believed responsible for setting attention and switching tasks is turned down when on the drug. The researchers say that this ties in with what people report as typical effects of psychedelic drugs, including feelings of being connected to everything and reduced senses of self or ego.
“Our findings move us one step closer to understanding mechanisms underlying how psilocybin works in the brain,” says Frederick Barrett, Ph.D., assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and a member of the school’s Center for Psychedelic and Consciousness Research. “This will hopefully enable us to better understand why it’s an effective therapy for certain psychiatric disorders, which might help us tailor therapies to help people more.”
Because of its deep-rooted location in the brain, the claustrum has been difficult to access and study. Last year, Barrett and his colleagues at the University of Maryland, Baltimore, developed a method to detect brain activity in the claustrum using functional magnetic resonance imaging (fMRI).
For this new study, the researchers used fMRI with 15 people and observed the claustrum brain region after the participants took either psilocybin or a placebo. They found that psilocybin reduced neural activity in the claustrum by 15% to 30%. This lowered activity also appeared to be associated with stronger subjective effects of the drug, such as emotional and mystical experiences. The researchers also found that psilocybin changed the way that the claustrum communicated with brain regions involved in hearing, attention, decision-making and remembering.
With the highly detailed imaging of the claustrum provided by fMRI, the researchers next hope to look at the mysterious brain region in people with certain psychiatric disorders such as depression and substance use disorder. The goal of these experiments will be to see what roles, if any, the claustrum plays in these conditions. The researchers also plan to observe the claustrum’s activity when under the influence of other psychedelics, such as salvinorin A, a hallucinogen derived from a Mexican plant.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Psilocybin
- Oregon Psilocybin Services: State issues first licenses
Mar. 23—The Oregon Health Authority (OHA) has issued the state's first psilocybin license as part of the nation's first regulatory framework for psilocybin services. The manufacturer license was ...
- Oregon issues first licenses for psilocybin manufacturers
These licenses are the next step in a program that the state has been building from the ground up since voters passed a framework for legal psilocybin use in the state in 2020. Earlier this month, ...
- Oregon’s first psilocybin facilitators are eager to deliver therapy
Hundreds of psilocybin facilitators from around the state have now graduated or are near the end of their programs.
- Oregon issues first license under psilocybin program
Oregon has issued its first license under its new system that offers controlled use of psilocybin to the public.
- Oregon approves first psilocybin manufacturing licenses
The second manufacturing license came on the heels of the first. The Oregon Health Authority on Thursday approved a license for Andreas and Jennifer Met of Medford. The couple co- ...
Go deeper with Google Headlines on:
Psilocybin
[google_news title=”” keyword=”psilocybin” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Psychedelics
- Hawaii Senators Approve Bill To Create Psychedelics Advisory Council To Prepare For Federal Legalization
A Hawaii Senate committee approved a House-passed bill on Wednesday that would create an advisory council to look into possible regulations to provide access to federal “breakthrough therapies” like ...
- Psychedelics Reform Update: Latest Moves In 9 Of 22 States With Existing Bills
Since last week’s update, more news has occurred around the country in the area of psychedelics reform. Here are the highlights: ...
- Stone Village Television Acquires Rights to Brian Muraresku’s Psychedelics Book ‘The Immortality Key’ (EXCLUSIVE)
Scott Steindorff and Dylan Russell of Stone Village Television are developing a multi-part TV series based on Brian Muraresku’s book, “The Immortality Key: The Secret History of the Religion With No ...
- Psychedelics Advocates Launch Political Action Committee
Psychedelics reform activists have formed a political action committee to lobby policymakers on the therapeutic potential of the powerful drugs.
- Majority Of Americans Back Legalizing Psychedelics Therapy And Federally Decriminalizing Substances Like Psilocybin, Poll Finds
A strong majority of Americans support legalizing and regulating psychedelics therapy, and most back federally decriminalizing substances like MDMA and psilocybin, according to a new poll. The survey ...
Go deeper with Google Headlines on:
Psychedelics
[google_news title=”” keyword=”psychedelics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]